AR086525A1 - Metodo de purificacion de anticuerpos - Google Patents

Metodo de purificacion de anticuerpos

Info

Publication number
AR086525A1
AR086525A1 ARP120101815A ARP120101815A AR086525A1 AR 086525 A1 AR086525 A1 AR 086525A1 AR P120101815 A ARP120101815 A AR P120101815A AR P120101815 A ARP120101815 A AR P120101815A AR 086525 A1 AR086525 A1 AR 086525A1
Authority
AR
Argentina
Prior art keywords
solution
buffer
obtaining
acetic acid
nacl
Prior art date
Application number
ARP120101815A
Other languages
English (en)
Inventor
Laure Landric-Burtin
Didier Duthe
Benoit Mothes
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of AR086525A1 publication Critical patent/AR086525A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804Affinity chromatography
    • B01D15/3809Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/165Extraction; Separation; Purification by chromatography mixed-mode chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)

Abstract

Reivindicación 1: Un método para purificar una proteína de una disolución que comprende: (a) una primera etapa de cromatografía que comprende: pasar dicha disolución sobre una primera columna de cromatografía; eluir un eluyente de proteína cruda de la primera columna de cromatografía usando un primer tampón de elución; y (b) una segunda etapa de cromatografía que comprende: pasar el eluyente de proteína cruda obtenido al final de la etapa (a) sobre una segunda columna de cromatografía; recuperar la proteína purificada de la segunda columna de cromatografía usando un segundo tampón de elusión, en el que cada uno de los tampones comprende Bis Tris.Reivindicación 38: Un método para preparar tampones adecuados para usarse en el método de una cualquiera de las reivindicaciones 1 a 37, que comprende las etapas de: i) crear una disolución con una concentración final de 15 a 25 mM Bis Tris y de 15 a 25 mM NaCl; ii) ajustar el pH de la disolución a un valor comprendido entre 7 y 8 con ácido acético; iii) recoger la mitad de la disolución, obteniendo de esta manera un tampón de equilibrado; iv) ajustar el pH de la mitad restante de la disolución de la etapa (iii) a un valor comprendido entre 4 y 5 con ácido acético; v) recoger la mitad de la disolución obtenida en la etapa (iv), obteniendo de esta manera un tampón de elusión; vi) ajustar el pH de la mitad restante de la disolución de la etapa (v) a un valor comprendido entre 3 y 4 con ácido acético, obteniendo de esta manera un tampón de elusión más; vii) recoger la mitad del tampón de equilibrado obtenido en la etapa (iii) y añadir NaCl para obtener una concentración final de NaCl comprendida entre 0,9 a 1,1 mM, obteniendo de esta manera un tampón de lavado y limpieza. Reivindicación 42: Uso de un tampón que comprende o consiste en Bis Tris, ácido acético, NaCl, y agua para purificar una proteína de una disolución por al menos una etapa de cromatografía.
ARP120101815A 2011-11-23 2012-05-23 Metodo de purificacion de anticuerpos AR086525A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2011/070768 WO2013075740A1 (en) 2011-11-23 2011-11-23 Antibody purification method

Publications (1)

Publication Number Publication Date
AR086525A1 true AR086525A1 (es) 2013-12-18

Family

ID=46125462

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120101815A AR086525A1 (es) 2011-11-23 2012-05-23 Metodo de purificacion de anticuerpos

Country Status (14)

Country Link
US (2) US10131714B2 (es)
JP (2) JP6437311B2 (es)
KR (1) KR102048598B1 (es)
CN (1) CN104039808B (es)
AR (1) AR086525A1 (es)
AU (2) AU2012342865A1 (es)
BR (1) BR112014012275A2 (es)
CA (1) CA2855491A1 (es)
IL (1) IL232558B (es)
MX (1) MX364908B (es)
RU (1) RU2603347C2 (es)
SG (1) SG11201402410RA (es)
TW (1) TWI643865B (es)
WO (2) WO2013075740A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013075740A1 (en) 2011-11-23 2013-05-30 Sanofi Antibody purification method
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
DK3301115T3 (da) * 2013-05-06 2022-01-31 Sanofi Sa Kontinuerlig flertrinsfremgangsmåde til oprensning af antistoffer
AR096713A1 (es) 2013-06-25 2016-01-27 Cadila Healthcare Ltd Proceso de purificación para anticuerpos monoclonales
CN103480346B (zh) * 2013-10-08 2016-04-06 天津工业大学 一种含大环化合物的新型亲和分离材质制备方法及应用
CN104628846B (zh) * 2013-11-06 2019-12-06 三生国健药业(上海)股份有限公司 重组蛋白质的纯化方法
WO2015105955A1 (en) 2014-01-08 2015-07-16 Flodesign Sonics, Inc. Acoustophoresis device with dual acoustophoretic chamber
US10329323B2 (en) * 2014-07-25 2019-06-25 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Method for purifying antibodies using PBS
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
WO2016106291A1 (en) * 2014-12-22 2016-06-30 Alexion Pharmaceuticals, Inc. Methods of purifying recombinant proteins
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
WO2017194597A1 (en) 2016-05-11 2017-11-16 Ge Healthcare Bioprocess R&D Ab Separation matrix
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
CN109311949B (zh) 2016-05-11 2022-09-16 思拓凡生物工艺研发有限公司 储存分离基质的方法
EP3455241B1 (en) 2016-05-11 2022-02-23 Cytiva BioProcess R&D AB Method of cleaning and/or sanitizing a separation matrix
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
US11760777B2 (en) 2017-04-26 2023-09-19 Bristol-Myers Squibb Company Methods of antibody production that minimize disulfide bond reduction
CA3085784A1 (en) 2017-12-14 2019-06-20 Flodesign Sonics, Inc. Acoustic transducer driver and controller
US11603527B2 (en) * 2017-12-27 2023-03-14 Global Life Sciences Solutions Usa Llc Method and kit for viral vector isolation
WO2019183334A1 (en) 2018-03-21 2019-09-26 Waters Technologies Corporation Non-antibody high-affinity-based sample preparation, sorbents, devices and methods
EP3546475A1 (en) * 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
CN112105927A (zh) * 2018-05-08 2020-12-18 沃特世科技公司 可用于pH梯度阳离子交换色谱法的方法、组合物和试剂盒
EP3636657A1 (en) 2018-10-08 2020-04-15 Ablynx N.V. Chromatography-free antibody purification method
CN113845562A (zh) * 2020-06-28 2021-12-28 佛山汉腾生物科技有限公司 目的蛋白纯化方法
WO2022234412A1 (en) 2021-05-03 2022-11-10 Lupin Limited A process for purification of fc-fusion proteins
US20230240961A1 (en) * 2022-01-28 2023-08-03 Praj Industries Limited Process for the preparation of antimalassezia powder

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930008447B1 (ko) * 1987-10-23 1993-09-04 쉐링 코포레이션 단백질 정제방법
CA2106612C (en) 1993-09-21 2001-02-06 Diana Pliura Displacement chromatography process
US5891741A (en) * 1997-05-16 1999-04-06 Coulter International Corp. Antibody-aminodextran-phycobiliprotein conjugates
CN1136317C (zh) * 1999-03-12 2004-01-28 中国人民解放军第四军医大学 单克隆抗体双段和单段的制备方法
US20020009445A1 (en) * 2000-07-12 2002-01-24 Yansheng Du Human beta-amyloid antibody and use thereof for treatment of alzheimer's disease
US6602855B2 (en) * 2001-04-30 2003-08-05 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons
SI1745075T1 (sl) 2004-04-21 2013-07-31 The Brigham And Women's Hospital, Inc. Poli-N-acetilglukozamin (PNAG/dPNAG) vezavni peptidi in postopki za njihovo uporabo
CA2583578C (en) 2004-10-21 2014-04-01 Ge Healthcare Bio-Sciences Ab Chromatography ligand
EP3312196B1 (en) 2005-03-23 2019-07-17 Genmab A/S Antibodies against cd38 for treatment of multiple myeloma
CN1814775A (zh) * 2005-12-06 2006-08-09 中国海洋大学 一种抗病毒活性寡聚肽的制备方法
EP1914242A1 (en) * 2006-10-19 2008-04-23 Sanofi-Aventis Novel anti-CD38 antibodies for the treatment of cancer
ES2364118T3 (es) 2007-07-11 2011-08-25 Novo Nordisk A/S Purificación de factor viii usando una resina de modo mixto o multimodal.
MY158903A (en) 2007-11-16 2016-11-30 Univ Rockefeller Antibodies specific for the protofibril form of beta-amyloid protein
KR20100128315A (ko) * 2008-02-29 2010-12-07 바이오겐 아이덱 엠에이 인코포레이티드 정제된 면역글로불린 융합 단백질 및 그의 정제 방법
WO2010009388A1 (en) 2008-07-18 2010-01-21 Talecris Biotherapeutics, Inc. Method of preparing alpha-1 proteinase inhibitor
JPWO2010071208A1 (ja) * 2008-12-19 2012-05-31 武田薬品工業株式会社 抗体の精製方法
AU2010205007A1 (en) 2009-01-13 2011-07-07 Ge Healthcare Bio-Sciences Ab Precipitation of biomolecules with negatively charged polymers
KR101224468B1 (ko) 2009-05-20 2013-01-23 주식회사 파멥신 신규한 형태의 이중표적항체 및 그 용도
ES2817802T3 (es) 2009-08-07 2021-04-08 Emd Millipore Corp Métodos para purificar una proteína objetivo de una o más impurezas en una muestra
US9527010B2 (en) 2009-09-25 2016-12-27 Ge Healthcare Bio-Sciences Corp. Separation system and method
WO2011049798A1 (en) 2009-10-20 2011-04-28 Merck Sharp & Dohme Corp. Use of mixed mode chromatography for the capture and purification of basic antibody products
ES2534936T3 (es) * 2010-08-02 2015-04-30 Ratiopharm Gmbh Método para producir y purificar una sialiltransferasa soluble activa
US20120238730A1 (en) 2011-03-15 2012-09-20 Abbott Laboratories Integrated approach to the isolation and purification of antibodies
WO2012135415A1 (en) * 2011-03-29 2012-10-04 Glaxosmithkline Llc Buffer system for protein purification
CN107421796B (zh) * 2011-06-17 2021-05-04 罗氏血液诊断股份有限公司 用于生物样品的组织加工的溶液
US9096648B2 (en) 2011-08-19 2015-08-04 Emd Millipore Corporation Methods of reducing level of one or more impurities in a sample during protein purification
CN104023743B (zh) 2011-10-25 2017-05-03 普罗西纳治疗有限公司 抗体制剂和方法
WO2013075740A1 (en) 2011-11-23 2013-05-30 Sanofi Antibody purification method

Also Published As

Publication number Publication date
CN104039808A (zh) 2014-09-10
US20140323698A1 (en) 2014-10-30
SG11201402410RA (en) 2014-06-27
MX364908B (es) 2019-05-13
TWI643865B (zh) 2018-12-11
RU2603347C2 (ru) 2016-11-27
AU2017245478B2 (en) 2019-05-16
AU2012342865A1 (en) 2014-06-19
US20190135942A1 (en) 2019-05-09
KR102048598B1 (ko) 2019-11-25
RU2014125063A (ru) 2015-12-27
MX2014006284A (es) 2014-10-24
KR20140094013A (ko) 2014-07-29
WO2013075849A1 (en) 2013-05-30
JP2017095505A (ja) 2017-06-01
US10131714B2 (en) 2018-11-20
JP6437311B2 (ja) 2018-12-12
TW201321402A (zh) 2013-06-01
BR112014012275A2 (pt) 2017-05-30
CN104039808B (zh) 2019-04-19
IL232558A0 (en) 2014-06-30
JP2015500798A (ja) 2015-01-08
AU2017245478A1 (en) 2017-11-02
IL232558B (en) 2018-08-30
CA2855491A1 (en) 2013-05-30
WO2013075740A1 (en) 2013-05-30

Similar Documents

Publication Publication Date Title
AR086525A1 (es) Metodo de purificacion de anticuerpos
AR121861A2 (es) MÉTODO PARA PREPARAR UNA COMPOSICIÓN DE IgG ENRIQUECIDA A PARTIR DE PLASMA
CY1123952T1 (el) Απομονωση και καθαρισμος αντισωματων αντι-il-13 με την χρηση χρωματογραφιας χημικης συγγενειας πρωτεινης α
MY144484A (en) Methods of purifying anti a beta antibodies
ES2492681T3 (es) Método cromatográfico para purificar proteínas que contienen FC
BR112013030628A2 (pt) "métodos para produção de uma proteína purificada de interesse utilizando uma matriz de cromatografia de afinidade (ca), e de um anticorpo purificado, fragmento de anticorpo ou proteína de fusão de fc utilizando a coluna de proteína a".
PH12013501128A1 (en) Antibody purification by cation exchange chromatography
WO2015191911A3 (en) Protein enriched microvesicles and methods of making and using the same
CU20170039A7 (es) Método de purificación del anticuerpo humanizado 9e4
ATE481482T1 (de) Verfahren zur vorbereitenden rna-reinigung mittels hplc
BR112012024550A2 (pt) processo para purificação de proteínas dependentes de vitamina k tal como o fator de coagulação ix
EA201070987A1 (ru) Очищенные гибридные белки иммуноглобулина и способы их очищения
AR062570A1 (es) Proceso para la purificacion de las proteinas que contienen fc
AR068534A1 (es) Un metodo para aumentar rasgos relacionados con el rendimiento en plantas, aumentando la expresion del factor de regulacion del desarrollo del polipeptido de translocacion de sarcoma sinovial
WO2015104359A3 (en) Method for purifying cys-linked antibody-drug conjugates
BR112012024956A2 (pt) processo para a purificação de uma proteína de fator de crescimento
BR112013025614A2 (pt) "métodos para purificação de hidrofobina ii e uso de um álcool para purificar a referida hidrofobina".
BR112014000278A2 (pt) método para o preparo de um concentrado de imunoglobulinas polivalentes
DK1960521T3 (da) Fremgangsmåde og test kit til separation, oprensning og genvinding af lang- og kortkædede nukleinsyrer
WO2011104307A3 (en) Ligands for antibody purification by affinity chromatography
EA201391605A1 (ru) Способы очистки вирусов с использованием гельпроникающей хроматографии
BR112014027994A2 (pt) métodos de cristalização para purificação de anticorpos monoclonais
AR111465A1 (es) Método para la purificación de anticuerpos análogos por el uso de cromatografía de intercambio de cationes
MY157846A (en) Process for the purification of fc-containing proteins
BR112015009055A2 (pt) método para purificar 1,4-diaminobutano, 1,4-diaminobutano, e poliamida

Legal Events

Date Code Title Description
FB Suspension of granting procedure